Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duration of Doxycycline Treatment in Patients With Multiple Erythema Migrans
NCT03337932Recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- May 2018
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of doxycycline in erythema migrans (EM) (3 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Occurrence of objective clinical manifestations of Lyme borreliosis and post-Lyme symptoms at 12 months. Started May 2018; status: recruiting.
02
Drugs
doxycycline
03
Conditions
erythema migrans (EM)
Beyond the preview
Go deeper on NCT03337932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03337932.